Growth Metrics

GoodRx Holdings (GDRX) Receivables - Other (2020 - 2026)

GoodRx Holdings recorded quarterly Receivables - Other of $11.9 million in Q1 2026, little changed quarter-over-quarter from $11.9 million in Q4 2025.

GoodRx Holdings' Receivables - Other history runs 3 years deep, the most recent figure standing at $11.9 million for Q1 2026.

  • In Q1 2026, Receivables - Other changed N/A year-over-year to $11.9 million; the TTM figure through Mar 2026 stood at $11.9 million (changed N/A YoY), while the FY2025 annual figure was $11.9 million, changed N/A from the prior year.
  • Receivables - Other came in at $11.9 million for Q1 2026 at GoodRx Holdings, roughly flat from $11.9 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $11.9 million in Q4 2025 to a low of $11.9 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn
10 GoodRx Holdings 1.05 Bn 814.83 Mn 112.95 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 11.90 Mn
Mar 31, 2026 11.90 Mn
Dec 31, 2025 11.90 Mn
Dec 31, 2025 11.90 Mn
Dec 31, 2020 5.70 Mn
Dec 31, 2020 5.70 Mn